Claro Advisors’s Immunogen Inc IMGN Stock Holding History

Claro Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-117	Closed	-$1K	–	994
2018 Q4	$1K	Buy	+117	New	+$710	﹤0.01%	1086

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claro Advisors's IMGN Position: Q1 2019 in Review

Claro Advisors sold out of Immunogen Inc (IMGN) in Q1 2019, closing a stake of 117 shares — an estimated $1K sold.

Claro Advisors first reported a position in IMGN in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 212 funds tracked by Wall St. Rank hold IMGN as of Q1 2019.

Claro Advisors reported no remaining Immunogen Inc position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 117 Immunogen Inc shares in Q1 2019, an estimated $1K.
Claro Advisors first reported a position in Immunogen Inc in Q4 2018 and held it in 1 quarter.
Claro Advisors's Immunogen Inc position peaked at $1K in Q4 2018.
212 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.